SUBSCRIBE
SUBSCRIBE

Cory Renauer and Heather McKenzie

Drug Development
Moderna’s RSV Vaccine Snags FDA Breakthrough Therapy Nod
The FDA granted Moderna’s RSV vaccine candidate Breakthrough Therapy Designation Monday.
January 18, 2023
 · 
1 min read
 · 
Cory Renauer and Heather McKenzie